Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Ind.
Department of Biostatistics, Indiana University School of Medicine & Richard M. Fairbanks School of Public Health, Indianapolis, Ind.
J Thorac Cardiovasc Surg. 2016 Nov;152(5):1423-1429.e1. doi: 10.1016/j.jtcvs.2016.07.070. Epub 2016 Aug 20.
We aimed to further validate the vasoactive-ventilation-renal score as a predictor of outcome in patients recovering from surgery for congenital heart disease. We also sought to determine the optimal time point within the early recovery period at which the vasoactive-ventilation-renal score should be measured.
We prospectively reviewed consecutive patients recovering from cardiac surgery within our intensive care unit between January 2015 and June 2015. The vasoactive-ventilation-renal score was calculated at 6, 12, 24, and 48 hours postoperatively as follows: vasoactive-ventilation-renal score = ventilation index + vasoactive-inotrope score + Δ creatinine [change in serum creatinine from baseline*10]. Primary outcome of interest was prolonged hospital length of stay, defined as length of stay in the upper 25%. Receiver operating characteristic curves were generated, and areas under the curve with 95% confidence intervals were calculated for all time points. Multivariable logistic regression modeling also was performed.
We reviewed 164 patients with a median age of 9.25 months (interquartile range, 2.6-58 months). Median length of stay was 8 days (interquartile range, 5-17.5 days). The area under the curve value for the vasoactive-ventilation-renal score as a predictor of prolonged length of stay (>17.5 days) was greatest at 12 hours postoperatively (area under the curve = 0.93; 95% confidence interval, 0.89-0.97). On multivariable regression analysis, after adjustment for potential confounders, the 12-hour vasoactive-ventilation-renal score remained a strong predictor of prolonged hospital length of stay (odds ratio, 1.15; 95% confidence interval, 1.10-1.20).
In a heterogeneous population of patients undergoing surgery for congenital heart disease, the novel vasoactive-ventilation-renal score calculated in the early postoperative recovery period can be a strong predictor of prolonged hospital length of stay.
我们旨在进一步验证血管活性-通气-肾脏评分作为先天性心脏病术后恢复患者结局的预测因子。我们还试图确定在早期恢复期间测量血管活性-通气-肾脏评分的最佳时间点。
我们前瞻性地回顾了 2015 年 1 月至 2015 年 6 月期间在我们的重症监护病房内接受心脏手术后恢复的连续患者。在术后 6、12、24 和 48 小时计算血管活性-通气-肾脏评分,如下所示:血管活性-通气-肾脏评分=通气指数+血管活性-正性肌力评分+Δ肌酐[血清肌酐基线值的变化*10]。主要观察结果是延长住院时间,定义为住院时间位于前 25%。生成了感兴趣的主要结果的受试者工作特征曲线,并计算了所有时间点的曲线下面积和 95%置信区间。还进行了多变量逻辑回归建模。
我们回顾了 164 名中位年龄为 9.25 个月(四分位距,2.6-58 个月)的患者。中位住院时间为 8 天(四分位距,5-17.5 天)。血管活性-通气-肾脏评分作为预测延长住院时间(>17.5 天)的指标,术后 12 小时的曲线下面积值最大(曲线下面积=0.93;95%置信区间,0.89-0.97)。在多变量回归分析中,在校正潜在混杂因素后,12 小时血管活性-通气-肾脏评分仍然是延长住院时间的强烈预测因子(比值比,1.15;95%置信区间,1.10-1.20)。
在接受先天性心脏病手术的异质患者人群中,在早期术后恢复期计算的新型血管活性-通气-肾脏评分可以是延长住院时间的有力预测因子。